Patent details
EP1337267 Title: USE OF BLOOD COAGULATION FACTOR XIII FOR TREATING HAEMOPHILIA A
Basic Information
- Publication number:
- EP1337267
- PCT Application Number:
- PCT/US/2001/047073
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP019925841
- PCT Publication Number:
- WO/2002/036155
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF BLOOD COAGULATION FACTOR XIII FOR TREATING HAEMOPHILIA A
- French Title of Invention:
- UTILISATION DU FACTEUR XIII DE COAGULATION SANGUINE DANS LE TRAITEMENT DE L'HEMOPHILIE A
- German Title of Invention:
- VERWENDUNG DES BLUTGERINNUNGSFAKTORS XIII FÜR DIE BEHANDLUNG DER HÄMOPHILIE A
- SPC Number:
Dates
- Filing date:
- 05/11/2001
- Grant date:
- 25/04/2007
- EP Publication Date:
- 25/04/2007
- PCT Publication Date:
- 10/05/2002
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 27/08/2003
- EP B1 Publication Date:
- 25/04/2007
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 05/11/2007
- Expiration date:
- 05/11/2021
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 05/11/2001
- Name:
- ZymoGenetics Inc.
- Address:
- 1201 Eastlake Avenue East, Seattle, WA 98102, United States (US)
Inventor
1
- Name:
- ÖHRSTRÖM Jan
- Address:
- United States (US)
2
- Name:
- ROSE Lynn, Massman
- Address:
- United States (US)
3
- Name:
- BISHOP Paul, D.
- Address:
- United States (US)
Priority
- Priority Number:
- 245751 P
- Priority Date:
- 03/11/2000
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 38/45;
| Filing date | Document type | Number of pages |
|---|